For frontline healthcare workers, the mental health impact from the pandemic is extending beyond career burnout. Much of the attention on the mental toll suffered by frontline workers has focused on post-traumatic stress disorder (PTSD). New research from a collaboration between Syracuse University and the University of Pittsburgh reveals that even those who are not formally diagnosed as suffering from […]
Nearly half a million people missed out on starting medication to lower their blood pressure during the Covid-19 pandemic, according to research supported by the British Heart Foundation (BHF) Data Science Centre at Health Data Research UK published today in Nature Medicine [1]. The researchers say that thousands of people could suffer an avoidable heart attack or stroke due to delays […]
Global willingness to accept a COVID-19 vaccine increased from 75.2% in 2021 to 79.1% in 2022, according to a new survey of 23 countries that represent more than 60% of the world’s population, published today in Nature Medicine. Vaccine acceptance decreased in eight countries however, and nearly one in eight vaccinated respondents were hesitant about receiving a booster dose. This third annual study, […]
Molnupiravir (taken as an 800mg dose twice daily for five days) does not reduce hospital admissions or deaths in vaccinated adults with COVID-19 infection who are at higher risk of mortality, according to the results of a randomised controlled trial, published in The Lancet journal. However, the patients treated at home with molnupiravir recovered quicker compared to the control group. Previous studies […]
The antiviral drug nirmatrelvir plus ritonavir (Paxlovid) was granted Emergency Use Authorization for treating COVID-19 in December 2021. In clinical trials, the antiviral was associated with an 88% reduction in hospitalization or death among high-risk, unvaccinated individuals with COVID-19. However, little was known at the time about whether Paxlovid could significantly benefit vaccinated individuals, as well as individuals infected with […]
An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by an expert from Kingston University has shown. The Covid Champion scheme was launched by the NHS South East London Integrated Care System in July last year, at a time when there was […]
With what some are calling a “tripledemic” of COVID-19, the influenza virus and respiratory syncytial virus, or RSV, soaring in many parts of the country, the holiday season will come with some tough decisions again this year: Should you go to that Thanksgiving gathering even though you woke up with the sniffles? Send your child to that school performance even […]
Development of myocarditis after SARS-CoV-2 vaccination is rare but appears to be more frequent among males aged 18-29 and especially after the second mRNA-1273 (Moderna) vaccine. The study is published in CMAJ (Canadian Medical Association Journal) on Nov. 21, 2022. “In this study, we found higher observed rates of myocarditis after receipt of mRNA vaccines than expected, but absolute rates were low,” […]
A study undertaken by management experts at Kingston University’s Business School and Maynooth University in Ireland has shown people in the early stages of their careers were more likely to be impacted by workplace stress during the Covid-19 pandemic than senior colleagues. The pandemic had been widely reported to impact negatively on the mental health of whole populations, particularly younger […]
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus. The new vaccine approach has been tested successfully in mice and has the potential to be a powerful tool for enhancing protection against COVID-19 infection and minimising ongoing viral spread. Made up […]
Recent Comments